Exane Derivatives’s Bank of Montreal BMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-65
Closed -$7.64K 815
2022
Q1
$7.64K Hold
65
﹤0.01% 682
2021
Q4
$6.97K Hold
65
﹤0.01% 604
2021
Q3
$6.45K Hold
65
﹤0.01% 720
2021
Q2
$6.65K Buy
+65
New +$6.42K ﹤0.01% 759
2021
Q1
Sell
-65
Closed -$4.94K 928
2020
Q4
$4.94K Hold
65
﹤0.01% 558
2020
Q3
$3.78K Hold
65
﹤0.01% 526
2020
Q2
$3.43K Sell
65
-2,400
-97% -$122K ﹤0.01% 474
2020
Q1
$123K Hold
2,465
0.03% 258
2019
Q4
$195K Hold
2,465
0.04% 261
2019
Q3
$182K Sell
2,465
-4,000
-62% -$291K 0.03% 265
2019
Q2
$489K Buy
+6,465
New +$495K 0.09% 174
2019
Q1
Sell
-14,764
Closed -$966K 680
2018
Q4
$966K Buy
+14,764
New +$1.09M 0.17% 122
2018
Q3
Sell
-1,775
Closed -$143K 699
2018
Q2
$136K Sell
1,775
-27,000
-94% -$2.08M 0.02% 297
2018
Q1
$2.15M Sell
28,775
-2,700
-9% -$212K 0.43% 57
2017
Q4
$2.52M Buy
31,475
+12,500
+66% +$975K 0.43% 39
2017
Q3
$1.44M Sell
18,975
-11,500
-38% -$858K 0.27% 70
2017
Q2
$2.24M Sell
30,475
-500
-2% -$35.4K 0.48% 50
2017
Q1
$2.32M Buy
+30,975
New +$2.34M 0.52% 60

Other funds holding BMO

Exane Derivatives's BMO Position: Q2 2022 in Review

Exane Derivatives sold out of Bank of Montreal (BMO) in Q2 2022, closing a stake of 65 shares — an estimated $7.64K sold.

Exane Derivatives first reported a position in BMO in Q1 2017 and held it in 18 quarters. The position peaked at $2.52M in Q4 2017. 488 funds tracked by Wall St. Rank hold BMO as of Q2 2022.

  • Exane Derivatives reported no remaining Bank of Montreal position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 65 Bank of Montreal shares in Q2 2022, an estimated $7.64K.
  • Exane Derivatives first reported a position in Bank of Montreal in Q1 2017 and held it in 18 quarters.
  • Exane Derivatives's Bank of Montreal position peaked at $2.52M in Q4 2017.
  • 488 funds tracked by Wall St. Rank held Bank of Montreal as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.